Use of an antagonist of HMGB1 in mice affected by malignant mesothelioma: a preliminary ultrasound and optical imaging study

BACKGROUND: Malignant mesothelioma (MM) is an aggressive tumor, with a poor prognosis, usually unresectable due to late diagnosis, mainly treated with chemotherapy. BoxA, a truncated form of “high mobility group box 1” (HMGB1), acting as an HMGB1 antagonist, might exert a defensive action against MM...

Descripción completa

Detalles Bibliográficos
Autores principales: Venturini, Massimo, Mezzapelle, Rosanna, La Marca, Salvatore, Perani, Laura, Spinelli, Antonello, Crippa, Luca, Colarieti, Anna, Palmisano, Anna, Marra, Paolo, Coppola, Andrea, Fontana, Federico, Carcano, Giulio, Tacchetti, Carlo, Bianchi, Marco, Esposito, Antonio, Crippa, Massimo P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821768/
https://www.ncbi.nlm.nih.gov/pubmed/35132475
http://dx.doi.org/10.1186/s41747-021-00260-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821768/
https://www.ncbi.nlm.nih.gov/pubmed/35132475
http://dx.doi.org/10.1186/s41747-021-00260-y

Ejemplares similares